Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018

Euro Surveill. 2018 Jul;23(27):1800323. doi: 10.2807/1560-7917.ES.2018.23.27.1800323.

Abstract

We describe a gonorrhoea case with combined high-level azithromycin resistance and ceftriaxone resistance. In February 2018, a heterosexual male was diagnosed with gonorrhoea in the United Kingdom following sexual intercourse with a locally resident female in Thailand and failed treatment with ceftriaxone plus doxycycline and subsequently spectinomycin. Resistance arose from two mechanisms combining for the first time in a genetic background similar to a commonly circulating strain. Urgent action is essential to prevent further spread.

Keywords: antimicrobial resistance; antimicrobial treatment, whole-genome sequencing; gonorrhoea; treatment failure.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Bacterial Agents / therapeutic use
  • Azithromycin / pharmacology
  • Ceftriaxone / pharmacology
  • Doxycycline / pharmacology
  • Drug Resistance, Bacterial / drug effects*
  • England
  • Gonorrhea / diagnosis
  • Gonorrhea / drug therapy*
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Neisseria gonorrhoeae / drug effects*
  • Neisseria gonorrhoeae / genetics
  • Neisseria gonorrhoeae / isolation & purification*
  • Sequence Analysis
  • Spectinomycin / therapeutic use*
  • Thailand
  • Travel
  • Treatment Failure

Substances

  • Anti-Bacterial Agents
  • Ceftriaxone
  • Azithromycin
  • Spectinomycin
  • Doxycycline